The use of liposomes bound to anti-IQGAP1 antibodies demonstrates significant promise in the field of glioma research, particularly due to the critical role that IQGAP1 plays in the progression of glioblastoma multiforme. Studies have shown that targeting IQGAP1 with specific antibodies can alter tumor growth dynamics, potentially leading to improved therapeutic outcomes for patients suffering from this aggressive form of brain cancer. Moreover, the diagnostic capabilities of these liposome-conjugated antibodies offer new avenues for early detection and monitoring of glioma, which could be pivotal in enhancing patient prognosis and treatment strategies.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-0988CT | Recombinant Mouse anti-Human IQGAP1 Monoclonal antibody (EML945) | ICC/IF, IHC-P, WB | |
MRO-0864-CN | Recombinant Rabbit Anti-IQGAP1 Monoclonal Antibody (JG38-74) | WB, IF, IHC, FC | Rabbit IgG |
VS3-WK489 | Rabbit Anti-IQGAP1 Recombinant Antibody (clone JG38-74) | WB, ELISA | Rabbit IgG |
VS3-XY3395 | Rabbit Anti-IQGAP1 Recombinant Antibody (clone R01-9S9) | WB, IHC-P, ICC, IF, FC | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY110. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.